Consistently, the aberrant hypomethylation status in the AHNAK gene promoter region from HCC patients’ PBMC DNA was verified in methylation-specific PCR (MSP) results of our previous studies (36). This evidence concerns the gene AHNAK and hepatocellular carcinoma.